NASDAQ: SION
Sionna Therapeutics Inc Earnings Dates, Reports, Calls

Sionna Therapeutics earnings were -$61.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SION earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$15.8M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SION reported annual earnings of -$61.7M, with 30.5% growth.

SION earnings history

Current Revenue
$0.0
Current Earnings
-$61.7M
Current Profit Margin
0%

SION Return on Equity

Insufficient data to display

SION undefined

Current Company
-51.9%
Current Industry
-0.4%
SION is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SION announces earnings.

SION undefined

Current Company
-35.18%
Current Industry
5.9%

SION vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SION-$59.06M-$61.69MN/A-$15.99
KROS-$184.00M-$187.35MN/A-$5.00
VALN$13.58M-$13.31MN/A-$0.17
PHAR$8.42M-$13.16MN/A-$0.20
SVRA-$95.61M-$95.88MN/A-$0.48

Sionna Therapeutics Earnings Reports & History FAQ

What were Sionna Therapeutics's earnings last quarter?

Sionna Therapeutics (NASDAQ: SION) reported Q4 2024 earnings per share (EPS) of -$3.18, up 18.67% year over year. Total SION earnings for the quarter were -$15.85 million. In the same quarter last year, Sionna Therapeutics's earnings per share (EPS) was -$3.91.

If you're new to stock investing, here's how to buy Sionna Therapeutics stock.

Is Sionna Therapeutics profitable or losing money?

As of the last Sionna Therapeutics earnings report, Sionna Therapeutics is currently losing money. Sionna Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$61.69 million, a 30.52% increase year over year.

What was SION's earnings growth in the past year?

As of Sionna Therapeutics's earnings date in Q2 2025, Sionna Therapeutics's earnings has grown year over year. SION earnings in the past year totalled -$61.69 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.